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In order to obtain sufficient quantities of HPV-16 capsid proteins for serological and immunological investigations we have previously expressed the L1 and L2 proteins in Sf-21 insect cells via baculovirus (&MNPV).
However, a n t i b o d s in human sera react with proteins from Sf-21 insect cells containing wild-type baculovirus.
Thus to obtain HPV-16 L1 and L2 proteins for serological studies, we have produced fusion proteins with cleavable polyhistidine tails to permit purification on nickel affinity columns. were cloned into the Nco-1 sites of pAcSGHis (C) and pAcSGHis (A) vectors which were transfected into -Sf-21 cells with wild type AcMNPV. The resulting (unpurified) HPV-16tl and L2 fusion proteins proteins respectively had major roducts of 61 and 67 KDa in western blots ? Figure 1) . Westerns were developed with monoclonal antibodies (Ll) [2] or a polyclonal rabbit antiserum (L2) raised against B-gal HPV-16 fusion proteins.
These apparent MWs are compatible with the anticipated MW derived from the prototypic HPV-16 sequence [ 31.
We are therefore currently optimizing the purification of the polyhistidine/HPV-16 fusion proteins in affinity columns for use in serological studies .
